NYC News Network | Local News Across New York City
Metropolitan Hospital, part of NYC Health + Hospitals, has earned national distinction for achieving a central line–associated bloodstream infection (CLABSI) rate of zero — a milestone reached by only 338 hospitals across the United States. The official press release was found on NYC Newswire.
The achievement is based on data collected through the Centers for Medicare & Medicaid Services (CMS) Healthcare-Associated Infections (HAI) metrics, which benchmark infection prevention and hospital safety nationwide. The performance is reported via the Centers for Disease Control and Prevention’s National Healthcare Safety Network, the nation’s most comprehensive infection surveillance system.
“The expertise and dedication of Metropolitan’s interdisciplinary teams continue to set the standard for patient safety nationwide,” said Julian S. John, MPA, CEO of NYC Health + Hospitals/Metropolitan. “This important recognition reflects our ongoing commitment to delivering reliable, patient-centered care across every unit.”
Achieving a CLABSI rate of zero requires rigorous, facility-wide adherence to evidence-based clinical practices, precise central line insertion and maintenance, and strict infection-prevention protocols. Teams across nursing, critical care, infection prevention, and quality management work collaboratively to assess device necessity, conduct maintenance audits, improve documentation, and reinforce sterile procedures.
The CMS HAI data, collected from October 2023 through September 2024, compares infection rates for patients treated in acute care hospitals, including adult, pediatric, neonatal, Medicare, and non-Medicare patients. These measures highlight how often patients acquire infections during inpatient stays relative to similar institutions.
“Achieving a zero CLABSI rate speaks to the clinical excellence driving our infection prevention efforts, where robust protocols, real-time surveillance, and interdisciplinary collaboration are critical to advancing the quality of care for every patient,” said Maria Castaldi, MD, FACS, Chief Quality Officer at Metropolitan Hospital.
“Our success in preventing central line–associated bloodstream infections demonstrates the power of a robust quality-improvement infrastructure that prioritizes patient safety at every level,” added Anitha Srinivasan, MD, MPH, FACS, Chief Medical Officer.
Christopher G. Wilson, MSN, RN, CNML, CENP, NEA-BC, FACHE, Chief Nursing Officer, emphasized the frontline effort: “This accomplishment reflects the expertise and dedication of our teams, whose focus on continuous education, precision in care, and unwavering patient advocacy helps ensure the highest standards of safety for each patient in our care.”
As infections grow more complex and challenging in today’s healthcare environment, Metropolitan Hospital’s zero CLABSI rate demonstrates the institution’s ongoing commitment to staff training, monitoring, and protocol improvement — ultimately ensuring safer, higher-quality care for all patients.